News
Pfizer's strong R&D pipeline, 7.5%+ dividend yield, & undervalued PE ratio make PFE stock a compelling investment opportunity ...
Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...
Winners of the ADGHW Innovation Awards 2025 addressed prenatal gene editing, robotic organ transplantation, precision drug ...
Josh Sullivan, the American pastor kidnapped at gunpoint in South Africa last week, was rescued Tuesday night after a wild shootout. He was abducted by a group of armed men during a raid of his small ...
Explore the latest changes in drug pricing as Trump aims to revamp Medicare negotiations for prescription drugs.
The immune system must be able to quickly attack invaders like viruses, while also ignoring harmless stimuli, or allergies can result. Immune cells are known to ignore or "tolerate" molecules found on ...
TD Cowen analyst Steve Scala maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The company’s ...
We recently published a list of 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Pfizer ...
Shares of Viking Therapeutics (VKTX) and Structure Therapeutics (GPCR) are on the rise on Monday after Pfizer (PFE) announced its decision to ...
Pokémon’s lovable pocket monsters have been a household favorite for over 30 years, inspiring games and collectibles — including trading cards that now can fetch thousands of dollars. Reporting for ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results